10-Q
Quarterly Report
AIM IMMUNOTECH INC.
AIM
NYSEAMER
CIK: 946644
File #: 001-27072
Balance Sheet
40 line items · 2 periods
XBRL
| Item | Jun 30, 2026 | Dec 31, 2025 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 9,900,000 | 2,985,000 |
Marketable securities | 64,000 | 62,000 |
Fair Value, Recurring | 64,000 | 62,000 |
Fair Value, Inputs, Level 1 - Fair Value, Recurring | 64,000 | 62,000 |
Accounts Receivable | — | 7,000 |
Other Non-Operating Current Assets | 468,000 | 241,000 |
Total current assets | 10,432,000 | 3,295,000 |
Property, Plant and Equipment | 54,000 | 71,000 |
Operating Lease Right-of-Use Asset | 260,000 | 378,000 |
Intangible Assets | 1,714,000 | 1,661,000 |
Patents | 1,657,000 | 1,599,000 |
Trademarks | 57,000 | 62,000 |
Other Non-Operating Non-Current Assets | 271,000 | 377,000 |
Total assets | 12,731,000 | 5,782,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
Current liabilities: | ||
Accounts Payable | 480,000 | 1,630,000 |
Other Current Liabilities | 586,000 | 795,000 |
Operating Lease Liability, Current | 259,000 | 250,000 |
Short-Term Debt | 3,621,000 | 3,549,000 |
Total current liabilities | 4,946,000 | 6,224,000 |
Long-term liabilities: | ||
Operating Lease Liability, Non-Current | 41,000 | 170,000 |
Long-Term Debt | — | 927,000 |
Other Non-Operating Non-Current Liabilities | — | 8,244,000 |
Fair Value, Recurring | — | 8,244,000 |
Fair Value, Inputs, Level 3 - Fair Value, Recurring | — | 8,244,000 |
Total liabilities | 4,987,000 | 15,565,000 |
Stockholders’ equity (deficit): | ||
Total Stockholders' Equity | 29,000 | 3,000 |
Total Stockholders' Equity | 455,312,000 | 431,000,000 |
Total Stockholders' Equity | (447,597,000) | (440,786,000) |
Total stockholders’ equity (deficit) | 7,744,000 | (9,783,000) |
Series G Preferred Stock - Preferred Stock | 529,000 | — |
Common Stock | 29,000 | 3,000 |
Additional Paid-in Capital | 455,312,000 | 431,000,000 |
Retained Earnings | (447,597,000) | (440,786,000) |
Total liabilities and stockholders’ equity | 12,731,000 | 5,782,000 |